Zhejiang Anglikang Pharmaceutical Hits Day Low Amid Price Pressure at CNY 25.65

Zhejiang Anglikang Pharmaceutical Co. experienced a notable decline today, with the stock dropping by 7.11% to reach an intraday low of CNY 25.65. This performance contrasts sharply with the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Zhejiang Anglikang has decreased by 1.68%, while its performance over the last month shows a modest gain of 6.76%. However, the stock has faced significant challenges over the past year, with a decline of 48.62%, compared to a 3.56% increase in the broader market index. Year-to-date, the stock is down 21.27%, further highlighting its underperformance relative to the market. Key financial metrics reveal a mixed picture for the company. The return on equity stands at 9.35%, and the price-to-book ratio is 3.05. Despite a high dividend yield of 1.00%, the company has struggled with long-term growth, as evidenced by a net sales growth rate of just 1.80% over the past five years. The inventory turnover ratio and operating profit figures also indicate areas of concern for the company’s operational efficiency.